Natco Pharma’s glycopyrrolate tablets, a generic version of the brand name drug Robinul, are used in conjunction with other medications to treat peptic ulcers. The tablets block the activity of acetylcholine in the body, decreasing stomach acid secretion.
Share prices of Natco Pharma rose 8 percent in response to news of the approval.
The drug manufacturer did not specify when the drug would hit the market.
More articles on supply chain:
Pa. cardiologist develops catheter inserted into the wrist
Medtronic’s new surgical device earns FDA clearance for use in epilepsy clinical trial
Protestors at ‘right to try’ rally in D.C. want access to experimental drugs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
